MF
AZN icon

Magnetar Financial’s AstraZeneca AZN Stock Holding History

Magnetar Financial’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-250,000
Closed -$18.6M – 184
2014
Q2 		$18.6M Buy
+250,000
New +$18.1M 0.31% 78

Other funds holding AZN

IA
Investor AB Stockholm, Sweden $15.1B AUM 29.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
VAM
Vanguard Asset Management London, Ec4n 8af $117B AUM

Magnetar Financial's AZN Position: Q1 2026 in Review

Magnetar Financial opened a new position in AstraZeneca (AZN) in Q1 2026: 9,449 shares worth $1.86M. The stake represents 0.02% of the portfolio and ranks #336 among its holdings. This is a return to the name: Magnetar Financial previously reported a position in AZN as recently as Q3 2024.

Magnetar Financial first reported a position in AZN in Q3 2018 and has held it in 20 quarters since. The position peaked at $59.7M in Q1 2024. 1,377 funds tracked by Wall St. Rank hold AZN as of Q1 2026.

  • Magnetar Financial held 9,449 shares of AstraZeneca worth $1.86M as of Q1 2026.
  • AstraZeneca was a new Magnetar Financial position in Q1 2026.
  • AstraZeneca made up 0.02% of Magnetar Financial's portfolio in Q1 2026, its #336 holding.
  • Magnetar Financial first reported a position in AstraZeneca in Q3 2018 and has held it in 20 quarters since.
  • Magnetar Financial's AstraZeneca position peaked at $59.7M in Q1 2024.
  • 1,377 funds tracked by Wall St. Rank held AstraZeneca as of Q1 2026.

Based on Magnetar Financial's 13F filing for Q1 2026, filed 13 May 2026.